Implants

3

Review clinical trials related to Implants. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal

o evaluate the radiologic proximity of mandibular dental implants placed less than 2 mm from the inferior alveolar canal using cone-beam computed tomography (CBCT), and to determine the relationship between implant-canal distance and the occurrence of postoperative neurosensory disturbances.

Participants needed: 100
Trial details
Age: 21+Biological sex: AllType: ObservationalSponsor: Cairo UniversityUpdated: Mar 19, 2026
Eligibility criteria

Age ≥ 21 years. [+3]

Incomplete records preventing outcome ascertainment (Froum et al., 2021). [+4]

Status: Not yet recruiting

Implants Placed With Crestal Sinus Approach Versus Osseodensification in Atrophic Posterior Maxilla

However, recently, most described techniques for posterior atrophic maxillary rehabilitation, are targeting more conservative, cost-effective and efficient methods for sinus elevation eliminating its lateral access. The aim of the present study is to evaluate and compare the long-term implant stability for implants placed by the novel crestal sinus approach versus osseodensification using Densa-bur in Atrophic Posterior Maxilla.

Participants needed: 28
Trial details
Age: 20+Biological sex: AllType: InterventionalSponsor: Misr International UniversityUpdated: Apr 18, 2025
Eligibility criteria

Edentulous atrophic posterior maxillary ridge. [+4]

Medically compromised patients. [+5]

Status: Recruiting

Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication

Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.

Participants needed: 225
Trial details
Biological sex: AllType: ObservationalSponsor: Copenhagen University Hospital at HerlevUpdated: Aug 21, 2024Locations: 1Duration: 2 Years
Eligibility criteria

Patient with cancer or osteoporosis, treated with antiresorptive treatment. [+3]

> 10 cigarettes daily [+7]